Cite

HARVARD Citation

    Hashad, R. et al. (2023). Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting. Chemistry. 29 (11), p. n/a. [Online]. 
  
Back to record